<h2 id="what-is-naloxone-">What is Naloxone? <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>
    <h2 id="a-pure-opioid-antagonist-used-to-reverse-the-effects-of-opioid-overdose-including-respiratory-depression-sedation-and-hypotension">A pure opioid antagonist used to reverse the effects of opioid overdose, including respiratory depression, sedation, and hypotension.</h2>
  </li>
</ul>
<h2 id="mechanism-of-action--pharmacokinetics-">Mechanism of Action &amp; Pharmacokinetics <sup id="fnref:1:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li><em>Competitively</em> binds to mu, delta, kappa, and sigma opioid receptors in the CNS, reversing or preventing opioid effects.</li>
  <li>Has a rapid onset of action within 1-2 minutes (IV) and a short duration of 30-60 minutes.</li>
  <li>Metabolized in the liver and excreted through the kidneys.</li>
</ul>
<h2 id="pharmacodynamics-">Pharmacodynamics <sup id="fnref:1:2" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<h3 id="cardiovascular">Cardiovascular</h3>
<ul>
  <li>Rapid reversal of opioids can cause hypertension, tachycardia, and even pulmonary edema or arrhythmias in severe cases.</li>
</ul>
<h3 id="respiratory">Respiratory</h3>
<ul>
  <li>Effectively reverses opioid-induced respiratory depression, restoring normal respiration.</li>
  <li>Rapid administration can precipitate withdrawal symptoms in opioid-dependent individuals.</li>
</ul>
<h2 id="indications-">Indications <sup id="fnref:1:3" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>Reversal of opioid overdose, particularly in cases of respiratory depression.</li>
  <li>Perioperative management of excessive sedation or respiratory depression due to opioids.</li>
</ul>
<h2 id="dosage">Dosage</h2>
<ul>
  <li><strong>Intravenous (IV):</strong>
    <ul>
      <li>Initial dose: 0.04 to 0.1 mg IV every 1-2 minutes to effect.</li>
      <li>0.25-0.5 mcg/kg in pediatrics <sup id="fnref:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></li>
    </ul>
  </li>
  <li><strong>Intramuscular (IM):</strong>
    <ul>
      <li>0.4 mg IM; may repeat as necessary.</li>
    </ul>
  </li>
  <li><strong>Intranasal:</strong>
    <ul>
      <li>4 mg as a single spray in one nostril; may repeat as necessary.</li>
    </ul>
  </li>
  <li><strong>IV Infusion:</strong>
    <ul>
      <li>3-10 mcg/kg/hr</li>
    </ul>
  </li>
</ul>
<h2 id="contraindications-">Contraindications <sup id="fnref:1:4" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>Hypersensitivity to naloxone or any of its components.</li>
  <li>Use with caution in opioid-dependent patients, as it may precipitate acute withdrawal symptoms.</li>
</ul>
<h2 id="complications-">Complications <sup id="fnref:1:5" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>Acute opioid withdrawal symptoms, including agitation, nausea, vomiting, tachycardia, and hypertension.</li>
  <li>Risk of pulmonary edema, particularly in patients with pre-existing cardiac conditions.</li>
  <li>Reversal of analgesia, leading to the return of pain.</li>
</ul>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Birdi T, Sullivan P. Ottawa Anesthesia Primer. Toronto, Ontario: Echo Book Publishing; 2012. <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:1:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:1:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:1:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a> <a href="#fnref:1:4" class="reversefootnote" role="doc-backlink">&#8617;<sup>5</sup></a> <a href="#fnref:1:5" class="reversefootnote" role="doc-backlink">&#8617;<sup>6</sup></a></p>
    </li>
    <li id="fn:2" role="doc-endnote">
      <table>
        <tbody>
          <tr>
            <td>[[@alma991028143802004336</td>
            <td>, Coté and Lerman's a practice of anesthesia for infants and children, 2018]]</td>
          </tr>
        </tbody>
      </table>
      <p><a href="#fnref:2" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>